KCNC1 | Potassium voltage-gated channel, Shaw-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/47634/ihc_cell_selected_60x60.jpg) | ![](/images/47634/111871_B_8_5_rna_selected_60x60.jpg) | Tissue enriched |
KCNC2 | Potassium voltage-gated channel, Shaw-related subfamily, member 2 | FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images/19664/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/19664/45838_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
KCNJ1 | Potassium inwardly-rectifying channel, subfamily J, member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images/26962/ihc_cell_selected_60x60.jpg) | ![](/images/26962/65936_A_1_1_rna_selected_60x60.jpg) | Tissue enriched |
KCNK9 | Potassium channel, subfamily K, member 9 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48553/123855_A_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
KEAP1 | Kelch-like ECH-associated protein 1 | Cancer-related genes FDA approved drug targets Predicted intracellular proteins
| ![](/images/25337/ihc_selected_60x60.jpg) | | ![](/images/5558/155233_A_5_5_selected_60x60.jpg) | ![](/images/25337/55899_B_8_3_rna_selected_60x60.jpg) | Expressed in all |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | | ![](/images/3288/8263_A_3_6_rna_selected_60x60.jpg) | Mixed |
LCK | LCK proto-oncogene, Src family tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | ![](/images/3494/if_selected_60x60.jpg) | | ![](/images/3816/10092_B_2_2_rna_selected_60x60.jpg) | Tissue enhanced |
LIPF | Lipase, gastric | Enzymes FDA approved drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/45930/ihc_cell_selected_60x60.jpg) | ![](/images/45930/105130_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
M6PR | Mannose-6-phosphate receptor (cation dependent) | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| ![](/images/34464/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/34464/66474_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
MAOA | Monoamine oxidase A | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | | | ![](/images/9437/30396_B_9_2_rna_selected_60x60.jpg) | Mixed |
MAOB | Monoamine oxidase B | Enzymes FDA approved drug targets Mitochondrial proteins Predicted membrane proteins
| | ![](/images/2328/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2328/7274_B_9_4_rna_selected_60x60.jpg) | Mixed |
MAP1A | Microtubule-associated protein 1A | FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | ![](/images/39064/1368_B10_3_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/39064/144721_B_8_4_rna_selected_60x60.jpg) | Tissue enriched |
MAP2 | Microtubule-associated protein 2 | FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | ![](/images/1984/5294_A_2_8_rna_selected_60x60.jpg) | Tissue enriched |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | ![](/images/26430/ihc_cell_selected_60x60.jpg) | ![](/images/3834/10782_A_2_6_rna_selected_60x60.jpg) | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | ![](/images/3835/11076_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
MAP4 | Microtubule-associated protein 4 | FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/38149/84134_B_1_4_rna_selected_60x60.jpg) | Expressed in all |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/5700/20814_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
MAPK3 | Mitogen-activated protein kinase 3 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | ![](/images/2683/ihc_cell_selected_60x60.jpg) | ![](/images/5700/20814_B_7_4_rna_selected_60x60.jpg) | Expressed in all |
MAPT | Microtubule-associated protein tau | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images/151/ihc_cell_selected_60x60.jpg) | ![](/images/151/156499_A_6_1_rna_selected_60x60.jpg) | Tissue enhanced |
MET | MET proto-oncogene, receptor tyrosine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| ![](/images/5282/ihc_selected_60x60.jpg) | | | ![](/images/5282/15801_A_8_1_rna_selected_60x60.jpg) | Expressed in all |
METAP2 | Methionyl aminopeptidase 2 | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | ![](/images/19095/75457_A_1_8_selected_60x60.jpg) | ![](/images/13025/28837_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
MGAM | Maltase-glucoamylase (alpha-glucosidase) | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | ![](/images/2270/32_E4_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2270/8419_B_8_5_rna_selected_60x60.jpg) | Group enriched |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13/156692_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
MMP10 | Matrix metallopeptidase 10 (stromelysin 2) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
MMP15 | Matrix metallopeptidase 15 (membrane-inserted) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| ![](/images/40390/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/40390/92316_A_3_6_rna_selected_60x60.jpg) | Mixed |
MMP8 | Matrix metallopeptidase 8 (neutrophil collagenase) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22935/50810_A_2_4_rna_selected_60x60.jpg) | Tissue enriched |
MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images/1238/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/63909/152372_A_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
MPL | MPL proto-oncogene, thrombopoietin receptor | Cancer-related genes CD markers Disease related genes FDA approved drug targets Predicted membrane proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Not detected |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | | ![](/images/14341/39080_B_8_5_rna_selected_60x60.jpg) | Group enriched |
MS4A2 | Membrane-spanning 4-domains, subfamily A, member 2 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/59967/ihc_cell_selected_60x60.jpg) | ![](/images/59967/135063_B_7_2_rna_selected_60x60.jpg) | Mixed |
MTR | 5-methyltetrahydrofolate-homocysteine methyltransferase | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
MUT | Methylmalonyl CoA mutase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | ![](/images/35971/if_selected_60x60.jpg) | ![](/images/35971/145837_A_4_7_selected_60x60.jpg) | ![](/images/35971/74640_B_8_3_rna_selected_60x60.jpg) | Expressed in all |
NFKB1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Cancer-related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins RAS pathway related proteins Transcription factors
| | | | ![](/images/4031/11359_A_8_5_rna_selected_60x60.jpg) | Expressed in all |
NOS3 | Nitric oxide synthase 3 (endothelial cell) | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | | ![](/images/2168/5988_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
NOXO1 | NADPH oxidase organizer 1 | FDA approved drug targets Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/71540/154564_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
NPC1L1 | NPC1-like 1 | FDA approved drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/70127/151478_B_8_6_rna_selected_60x60.jpg) | Group enriched |
NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | ![](/images/4248/13405_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
NR3C2 | Nuclear receptor subfamily 3, group C, member 2 | Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9155/31355_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
OPRM1 | Opioid receptor, mu 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/14509/ihc_cell_selected_60x60.jpg) | ![](/images/14509/34609_B_4_5_rna_selected_60x60.jpg) | Tissue enhanced |
P2RY12 | Purinergic receptor P2Y, G-protein coupled, 12 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14518/33943_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
PAH | Phenylalanine hydroxylase | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | ![](/images/28407/1399_C5_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/28407/155687_B_8_6_rna_selected_60x60.jpg) | Group enriched |
PDE3A | Phosphodiesterase 3A, cGMP-inhibited | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| ![](/images/14492/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/14492/34301_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
PDE5A | Phosphodiesterase 5A, cGMP-specific | Enzymes FDA approved drug targets Predicted intracellular proteins
| | ![](/images/4729/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/4729/13328_A_3_7_rna_selected_60x60.jpg) | Expressed in all |
PDE7A | Phosphodiesterase 7A | Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/27340/ihc_cell_selected_60x60.jpg) | ![](/images/27340/57247_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
PDE8B | Phosphodiesterase 8B | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | ![](/images/36912/1054_B12_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/36912/79380_A_3_2_rna_selected_60x60.jpg) | Tissue enriched |
PDGFRB | Platelet-derived growth factor receptor, beta polypeptide | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | ![](/images/28499/if_selected_60x60.jpg) | | ![](/images/3842/10176_B_9_3_rna_selected_60x60.jpg) | Mixed |
PDXK | Pyridoxal (pyridoxine, vitamin B6) kinase | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| ![](/images/30196/ihc_selected_60x60.jpg) | | | ![](/images/30196/65230_B_5_2_rna_selected_60x60.jpg) | Expressed in all |
PGR | Progesterone receptor | Cancer-related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images/8428/ihc_cell_selected_60x60.jpg) | ![](/images/8428/21814_B_8_5_rna_selected_60x60.jpg) | Group enriched |
PLA2G1B | Phospholipase A2, group IB (pancreas) | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted secreted proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images/60803/ihc_cell_selected_60x60.jpg) | ![](/images/60803/135493_A_2_5_rna_selected_60x60.jpg) | Tissue enriched |